


Ask a doctor about a prescription for XICIL 1500 MG ORAL SOLUTION POWDER
Package Leaflet: Information for the User
XICIL 1500 mg Powder for Oral Solution EFG
Glucosamine Sulfate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
XICIL belongs to the group of medicines called other anti-inflammatory and anti-rheumatic non-steroidal compounds.
XICIL is indicated to relieve symptoms produced by mild to moderate knee osteoarthritis.
Do not take XICIL
Warnings and precautions
You should consult your doctor to rule out the presence of other joint diseases for which other treatments should be considered.
Children and adolescents
Do not take XICIL if you are under 18 years old.
Other medicines and XICIL
Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines, including those obtained without a prescription.
Caution is recommended if XICIL is administered in combination with other medicines, especially with:
Taking XICIL with food and drinks
Dissolve the contents of the XICIL sachet in a glass of water and take it once a day, preferably with meals.
Pregnancy, breastfeeding, and fertility
XICIL should not be used during pregnancy.
The use of glucosamine is not recommended during breastfeeding.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
No studies have been conducted on how XICIL affects the ability to drive and use machines. However, if you experience dizziness or drowsiness when taking XICIL, do not drive or use machines (see section 4 "Possible side effects").
XICIL contains sodium, sorbitol, and aspartame
This medicine contains 151 mg of sodium (main component of table/cooking salt) per sachet. This is equivalent to 7.6% of the maximum recommended daily sodium intake for an adult.
This medicine contains 2028.5 mg of sorbitol per sachet.
Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to certain sugars, or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult your doctor before taking this medicine.
This medicine contains 2.5 mg of aspartame per sachet.
Aspartame contains a source of phenylalanine that may be harmful in case of phenylketonuria (PKU), a rare genetic disease in which phenylalanine accumulates due to the body's inability to eliminate it correctly.
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will adjust the dose according to your condition.
Method of administration and dosage
The normal starting dose is one sachet (dissolved in a glass of water) once a day, preferably with meals.
For oral use.
Duration of treatment
Glucosamine is not indicated for the treatment of acute painful symptoms. Relief of symptoms (especially pain relief) may not be noticed until after several weeks of treatment and, in some cases, even longer. If you do not experience relief of symptoms in 2-3 months, consult your doctor or pharmacist, as you may need to consider other treatments.
If you take more XICIL than you should
If you take more XICIL than you should, or if another person or child takes this medicine, tell your doctor or pharmacist.
The signs and symptoms of overdose with glucosamine include headache, dizziness, confusion, joint pain, nausea, vomiting, diarrhea, or constipation. Do not continue taking XICIL at the slightest presence of the aforementioned symptoms.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, Phone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take XICIL
Do not take a double dose to make up for forgotten doses.
If you stop taking XICIL
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
These symptoms may indicate that you are suffering a severe allergic reaction to this medicine. The most frequently observed side effects are:
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Frequency not known (cannot be estimated from the available data)
If you consider that any of the side effects you are suffering from is serious, or if you notice any side effect not mentioned in this leaflet, tell your doctor or pharmacist.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish national reporting system "Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es". By reporting side effects, you can help provide more information on the safety of this medicine.
This medicine does not require special storage conditions.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the sachet and carton after CAD or EXP. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of XICIL
The active substance is glucosamine. Each XICIL sachet contains 1,500 mg of glucosamine sulfate as glucosamine sulfate sodium chloride, equivalent to 1,178 mg of glucosamine.
The other ingredients are: aspartame (E-951), sorbitol (E-420), sodium, citric acid, and macrogol 4000.
Appearance of the product and pack contents
The powder is white crystalline and odorless and is packaged in single-dose sachets.
Each pack contains 20 or 30 single-dose sachets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Cooper Consumer Health B.V.
Verrijn Stuartweg 60,
1112 AX Diemen,
Netherlands
Manufacturer
Rottapharm, Ltd.
Damastown Industrial Park
Mulhuddart, Dublin 15
Ireland
or
SIGMAR ITALIA S.r.l.
Via Sombrero, 11
24011 – Almè (Bergamo) - Italy
You can obtain further information on this medicine by contacting the local representative of the marketing authorization holder:
Vemedia Pharma Hispania, S.A.
C/ Aragón, 182, 5ª planta
08011 – Barcelona
Spain
Date of the last revision of this leaflet:October 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for XICIL 1500 MG ORAL SOLUTION POWDER – subject to medical assessment and local rules.